Literature DB >> 3751679

Computed tomography and 131I-MIBG scintigraphy in the diagnosis of pheochromocytoma.

M Koizumi, K Endo, H Sakahara, T Nakashima, Y Nakano, K Nakao, K Torizuka.   

Abstract

In order to evaluate the usefulness of computed tomography (CT) and 131I meta-iodobenzylguanidine (131I-MIBG) scintigraphy for the localization of pheochromocytoma, a prospective study was undertaken in 23 patients with possible pheochromocytoma. Seventeen tumors were identified in 13 patients. Two tumors were extra-adrenal. CT was superior for locating tumors in the adrenal glands while 131I-MIBG scintigraphy was more useful in the detection of extra-adrenal pheochromocytoma. Together with adrenal and extra-adrenal pheochromocytoma, the sensitivity for locating the tumor was calculated as 82 per cent (14/17) for CT and 76 per cent (13/17) for 131I-MIBG scintigraphy, respectively. One adrenal tumor (1 cm in size) only was missed by both methods. No false positive CT scans of 131I-MIBG scintigraphy were obtained in the remaining 10 patients who had possible pheochromocytoma but were excluded. These results indicated that CT and 131I-MIBG scintigraphy were both useful tools for detecting pheochromocytoma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3751679     DOI: 10.1177/028418518602700310

Source DB:  PubMed          Journal:  Acta Radiol Diagn (Stockh)        ISSN: 0567-8056


  1 in total

1.  131I-metaiodobenzylguanidine therapy for malignant pheochromocytoma.

Authors:  H Sakahara; K Endo; T Saga; M Hosono; H Kobayashi; J Konishi
Journal:  Ann Nucl Med       Date:  1994-05       Impact factor: 2.668

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.